Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Julg

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|January 25, 2011
Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infectionBoris Julg, Eshia S Moodley, Ying Qi, et al.
Iscience|March 22, 2021
Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2Ang Gao, Zhilin Chen, Assaf Amitai, et al.
Cell Reports|May 26, 2021
Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cellsEvan D Rossignol, Anne-Sophie Dugast, Hacheming Compere, et al.
Iscience|April 20, 2026
Breast milk antibody Fc signatures track with HIV transmission during breastfeeding in ART-naïve mothersNadege Nziza, Wonyeong Jung, Yunjoo Lee, et al.
Cell Host & Microbe|May 21, 2009
Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive populationBoris Julg, Shabashini Reddy, Mary van der Stok, et al.
Journal of Virology|November 18, 2011
Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individualsJaclyn K Wright, Zabrina L Brumme, Boris Julg, et al.
Nature Protocols|March 6, 2026
A scalable, low-cost, sample hashing workflow for multiomic single-cell analysis using the Seq-Well S<sup>3</sup> platformDaniela D Russo, Sarah L Quinn, Olha Kholod, et al.
Mbio|March 10, 2021
Viral Rebound Kinetics Correlate with Distinct HIV Antibody FeaturesYannic C Bartsch, Carolin Loos, Evan Rossignol, et al.
NPJ Vaccines|January 31, 2026
Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infectionShlomi Ilan, Yannic Bartsch, Wonyeong Jung, et al.
JCI Insight|September 6, 2019
Predicting the broadly neutralizing antibody susceptibility of the HIV reservoirWen-Han Yu, David Su, Julia Torabi, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|January 25, 2011
Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infectionBoris Julg, Eshia S Moodley, Ying Qi, et al.
Iscience|March 22, 2021
Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2Ang Gao, Zhilin Chen, Assaf Amitai, et al.
Cell Reports|May 26, 2021
Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cellsEvan D Rossignol, Anne-Sophie Dugast, Hacheming Compere, et al.
Iscience|April 20, 2026
Breast milk antibody Fc signatures track with HIV transmission during breastfeeding in ART-naïve mothersNadege Nziza, Wonyeong Jung, Yunjoo Lee, et al.
Cell Host & Microbe|May 21, 2009
Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive populationBoris Julg, Shabashini Reddy, Mary van der Stok, et al.
Journal of Virology|November 18, 2011
Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individualsJaclyn K Wright, Zabrina L Brumme, Boris Julg, et al.
Nature Protocols|March 6, 2026
A scalable, low-cost, sample hashing workflow for multiomic single-cell analysis using the Seq-Well S<sup>3</sup> platformDaniela D Russo, Sarah L Quinn, Olha Kholod, et al.
Mbio|March 10, 2021
Viral Rebound Kinetics Correlate with Distinct HIV Antibody FeaturesYannic C Bartsch, Carolin Loos, Evan Rossignol, et al.
NPJ Vaccines|January 31, 2026
Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infectionShlomi Ilan, Yannic Bartsch, Wonyeong Jung, et al.
JCI Insight|September 6, 2019
Predicting the broadly neutralizing antibody susceptibility of the HIV reservoirWen-Han Yu, David Su, Julia Torabi, et al.
Pageof 7